Literature DB >> 10420422

Lymphedema prevention and management knowledge in women treated for breast cancer.

D D Coward1.   

Abstract

PURPOSE/
OBJECTIVES: To describe what women treated for breast cancer know about upper extremity lymphedema, what they recall being told to help prevent lymphedema, what preventive strategies they used, and, if lymphedema occurred, factors related to its occurrence and strategies they used to manage it.
DESIGN: Descriptive, correlational survey.
SETTING: Survivor-established Breast Cancer Resource Center. SAMPLE: 72 women with breast cancer who returned a mailed questionnaire that was enclosed with a quarterly newsletter.
METHODS: A survey instrument, the Lymphedema Knowledge Scale, developed from National-Lymphedema Network guidelines to prevent upper extremity lymphedema. Data that was analyzed using descriptive statistics, chi square, and t-tests. MAIN RESEARCH VARIABLES: Lymphedema knowledge, lymphedema occurrence, and lymphedema prevention and management strategies.
FINDINGS: Although many respondents were aware of their risk for lymphedema, their knowledge and use of prevention strategies were poor. Most knowledge was obtained from surgeons, reading materials, and breast cancer survivors. Occurrence of lymphedema was significantly associated only with radiation therapy to breast and axilla and use of any prevention strategy. The 27 women experiencing lymphedema used several management strategies to control the condition.
CONCLUSIONS: The few women who had knowledge of most of the recommended guidelines for lymphedema prevention and management did not recall nurses as resources. Research in a larger sample is needed to better examine the association between preventive practices and lymphedema occurrence. IMPLICATIONS FOR NURSING PRACTICE: Nurses could do more to inform patients before and during breast cancer treatment about their risk for lymphedema and the need for prompt diagnosis and treatment of the condition. Until strategies for lymphedema prevention are researched further, nurses should be cautious in counseling about lymphedema prevention.

Entities:  

Mesh:

Year:  1999        PMID: 10420422

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  6 in total

1.  SELF-REPORTED MANAGEMENT OF BREAST CANCER-RELATED LYMPHOEDEMA.

Authors:  Elise Radina; Jane Armer; Debbie Daunt; Julie Dusold; Scott Culbertson
Journal:  J Lymphoedema       Date:  2007-10

2.  A pilot randomized trial evaluating low-level laser therapy as an alternative treatment to manual lymphatic drainage for breast cancer-related lymphedema.

Authors:  Sheila H Ridner; Ellen Poage-Hooper; Collin Kanar; Jennifer K Doersam; Stewart M Bond; Mary S Dietrich
Journal:  Oncol Nurs Forum       Date:  2013-07       Impact factor: 2.172

3.  Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life.

Authors:  Sheila H Ridner; Mary S Dietrich; Nancy Kidd
Journal:  Support Care Cancer       Date:  2011-05       Impact factor: 3.603

4.  Changes in arm tissue composition with slowly progressive weight-lifting among women with breast cancer-related lymphedema.

Authors:  Xiaochen Zhang; Justin C Brown; Electra D Paskett; Babette S Zemel; Andrea L Cheville; Kathryn H Schmitz
Journal:  Breast Cancer Res Treat       Date:  2017-04-08       Impact factor: 4.872

5.  Decisional support throughout the cancer journey for older women diagnosed with early stage breast cancer: a single institutional study.

Authors:  Roseanna Presutti; Laura D'Alimonte; Merrylee McGuffin; Hanbert Chen; Edward Chow; Jean-Philippe Pignol; Lisa Di Prospero; Mary Doherty; Alex Kiss; Jennifer Wong; Justin Lee; Stanley Liu; Ellen Warner; Maureen Trudeau; Deb Feldman-Stewart; Tamara Harth; Ewa Szumacher
Journal:  J Cancer Educ       Date:  2014-03       Impact factor: 2.037

6.  Increasing public and provider knowledge of lymphedema: evaluation of the lymphedema roadshow.

Authors:  Maria Mathews; Greg Bursey; Amanda Park; Pamela Hodgson; Pat West; Jon Church
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.